Daniela Cargnelutti

573 total citations
8 papers, 283 citations indexed

About

Daniela Cargnelutti is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Daniela Cargnelutti has authored 8 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Daniela Cargnelutti's work include Multiple Sclerosis Research Studies (5 papers), Acute Ischemic Stroke Management (2 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). Daniela Cargnelutti is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Acute Ischemic Stroke Management (2 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). Daniela Cargnelutti collaborates with scholars based in Italy. Daniela Cargnelutti's co-authors include Gian Luigi Gigli, Giovanni Merlino, Mariarosaria Valente, Pierluigi Dolso, Anna Serafini, Lara Fratticci, Marilena Aiello, Roberto Eleopra, Cinzia Cecchetto and Delia D’Amico and has published in prestigious journals such as Frontiers in Immunology, Sleep Medicine and Journal of the International Neuropsychological Society.

In The Last Decade

Daniela Cargnelutti

7 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Cargnelutti Italy 7 196 76 55 50 41 8 283
Lara Fratticci Italy 8 144 0.7× 114 1.5× 165 3.0× 124 2.5× 140 3.4× 11 375
Luc Vleugels Belgium 11 275 1.4× 9 0.1× 30 0.5× 69 1.4× 45 1.1× 15 362
Jana Poettgen Germany 11 350 1.8× 10 0.1× 26 0.5× 103 2.1× 14 0.3× 15 421
Recep Alp Türkiye 11 136 0.7× 14 0.2× 50 0.9× 161 3.2× 29 0.7× 24 384
R. John Kimoff Canada 10 72 0.4× 105 1.4× 58 1.1× 52 1.0× 115 2.8× 24 441
Nadine Akbar Canada 12 371 1.9× 8 0.1× 27 0.5× 97 1.9× 54 1.3× 23 457
P. Scherer Germany 9 193 1.0× 12 0.2× 11 0.2× 104 2.1× 29 0.7× 12 296
Dana Serafin United States 8 351 1.8× 10 0.1× 24 0.4× 83 1.7× 32 0.8× 8 455
Jessica Englert United States 9 206 1.1× 8 0.1× 28 0.5× 57 1.1× 48 1.2× 13 406
Heather Rosehart Canada 11 280 1.4× 12 0.2× 11 0.2× 116 2.3× 18 0.4× 19 364

Countries citing papers authored by Daniela Cargnelutti

Since Specialization
Citations

This map shows the geographic impact of Daniela Cargnelutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Cargnelutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Cargnelutti more than expected).

Fields of papers citing papers by Daniela Cargnelutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Cargnelutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Cargnelutti. The network helps show where Daniela Cargnelutti may publish in the future.

Co-authorship network of co-authors of Daniela Cargnelutti

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Cargnelutti. A scholar is included among the top collaborators of Daniela Cargnelutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Cargnelutti. Daniela Cargnelutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ricci, Carolina, Nicola Giacchè, Simone Lorenzut, et al.. (2025). Tryptophan pathway profiling in multiple sclerosis patients treated with ocrelizumab. Frontiers in Immunology. 16. 1603663–1603663.
2.
Mansutti, Irene, et al.. (2022). Delirium prevalence, risk factors and outcomes among patients with acute stroke: A multi-centre observational study. Journal of Vascular Nursing. 40(4). 172–180. 6 indexed citations
3.
Lorenzut, Simone, et al.. (2021). Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment. Multiple Sclerosis and Related Disorders. 49. 102781–102781. 7 indexed citations
4.
Merlino, Giovanni, et al.. (2019). Efficacy and Safety of Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and Pre–Existing Disability. Journal of Clinical Medicine. 8(3). 400–400. 13 indexed citations
5.
Merlino, Giovanni, Massimo Sponza, Gian Luigi Gigli, et al.. (2018). Prior Use of Antiplatelet Therapy and Outcomes after Endovascular Therapy in Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single-Center Experience. Journal of Clinical Medicine. 7(12). 518–518. 12 indexed citations
6.
Cecchetto, Cinzia, Marilena Aiello, Delia D’Amico, et al.. (2014). Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease. Journal of the International Neuropsychological Society. 20(10). 1004–1014. 48 indexed citations
7.
Merlino, Giovanni, Lara Fratticci, Mariarosaria Valente, et al.. (2008). Prevalence of ‘poor sleep’ among patients with multiple sclerosis: An independent predictor of mental and physical status. Sleep Medicine. 10(1). 26–34. 163 indexed citations
8.
Cazzato, Giuseppe, Rodolfo M. Antonello, Fabrizio Monti, et al.. (1995). Double-Blind, Placebo-Controlled, Randomized, Crossover Trial of High-Dose Methylprednisolone in Patients with Chronic Progressive Form of Multiple Sclerosis. European Neurology. 35(4). 193–198. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026